Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ARG1 | P05089 | 5/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2806367 | 1.00 | SLC1A2 (0.59) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL11511876 | 1.00 | SLC1A2 (0.59) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL11511873 | 1.00 | SLC1A2 (0.59) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL7322888 | 0.81 | SLC1A2 (0.48) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL28948796 | 0.81 | SLC1A2 (0.43) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL11107498 | 0.80 | SLC1A2 (0.46) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL9511237 | 0.76 | SLC1A2 (0.39) | SLC1A2MEN1BLMKMT2AALDH1A1 | |
| SCHEMBL4339884 | 0.75 | SLC1A2 (0.43) | SLC1A2MEN1BLMKMT2APKM | |
| SCHEMBL4332743 | 0.75 | SLC1A2 (0.43) | SLC1A2MEN1BLMKMT2AALDH1A1 | |
| SCHEMBL1364961 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108269991-A | Preparation method of zinc-bismuth alloy powder for flexible battery cathode | 上海移宇科技股份有限公司 | 2018-07-10 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-1675595-A | Use of salts of layered double hydroxides | CLARIANT GMBH (DE) | 2005-09-28 | — | — | CN | claimed |
| EP-1529247-A1 | USE OF SALTS OF LAYERED DOUBLE HYDROXIDES | Clariant GmbH (DE) | 2005-05-11 | — | — | EP | claimed |
| WO-2004019138-A1 | USE OF SALTS OF LAYERED DOUBLE HYDROXIDES | CLARIANT GMBH (DE) | 2004-03-04 | — | — | WO | claimed |
| US-20250092395-A1 | A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2025-03-20 | — | — | US | disclosed |
| EP-4469042-A1 | A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE | Albert-Ludwigs-Universität Freiburg (DE) | 2024-12-04 | — | — | EP | disclosed |
| CN-118785903-A | GLUN2D inhibitors for the treatment or relapse prevention of depressive episodes | 阿尔伯特-路德维希-弗莱堡大学 | 2024-10-15 | — | — | CN | disclosed |
| WO-2023144163-A1 | A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2023-08-03 | — | — | WO | disclosed |
| EP-4217071-A1 | TRICYCLIC PYRIDONES AND PYRIMIDONES | Erasca, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-4204100-A1 | HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE | L'OREAL (FR) | 2023-07-05 | — | — | EP | disclosed |
| EP-0655656-A1 | Toner for developing electrostatic image | TOMOEGAWA PAPER CO. LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |
| US-5399693-A | Substituted piperazine-2-carboxylic acids and derivatives thereof | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-03-21 | — | — | US | disclosed |
| EP-0617337-A2 | Toner for developing electrostatic image | TOMOEGAWA PAPER CO. LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
| EP-0159889-B1 | 4-SUBSTITUTED PIPERAZINE-2-CARBOXYLIC ACIDS PROCESS AND PHARMACEUTICAL COMPOSITIONS | BTG INTERNATIONAL LIMITED (GB) | 1992-09-30 | — | — | EP | disclosed |
| EP-0159889-A2 | 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions | BTG INTERNATIONAL LIMITED (GB) | 1985-10-30 | — | — | EP | disclosed |
| US-4142061-A | FOR STABILIZING COBALT CABONYL CATALYST | CHEVRON RESEARCH COMPANY (US) | 1979-02-27 | — | — | US | disclosed |
| US-4096191-A | Hydroformylation of olefins using azoxy-dentated ligands | CHEVRON RESEARCH COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092395-A1 | A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE | GRIN2A, GRIN2B, GRIN2C | SLC1A2 27/4885MEN1 4780/4885BLM 4358/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | SLC1A2 4244/4885MEN1 2029/4885BLM 3099/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | SLC1A2 3491/4885MEN1 748/4885BLM 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.